Merve Boyraz
Merve Boyraz has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Servet Yüce
Department of Public Health İstanbul Provincial Health Directorate İstanbul Türkiye
7 shared publications - Edin Botan
Division of Pediatric Intensive Care, Department of Pediatrics, Ankara University School of Medicine, Ankara, Türkiye
6 shared publications - Emine Ulu Botan
Department of Public Health, Van Provincial Health Directorate, TR Ministry of Health, Van, Türkiye
3 shared publications - Muhterem Duyu
Pediatric Intensive Care Unit, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Medeniyet University Faculty of Medicine, İstanbul, Türkiye
3 shared publications - Abdulrahman Özel
Pediatric Intensive Care Unit, Department of Pediatrics, Bağcılar Training and Research Hospital, University of Health Sciences Türkiye, Istanbul, Türkiye
2 shared publications - Ayşe Aşık
Pediatric Intensive Care Unit, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Medeniyet University Faculty of Medicine, İstanbul, Türkiye
2 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 41 (3) , 661-669
Subclavian central venous catheterization in critically ill children in Türkiye: a safe and feasible approach in a single-center experience
Background: Central venous catheterization (CVC) is an essential procedure in the management of critically ill pediatric patients. However, the optimal catheter insertion site remains controversial due to varying complication rates. This study aimed to evaluate the feasibility and safety of subclavian vein (SCV) catheterization compared to femoral vein (FV) and internal jugular vein (IJV) access in a pediatric intensive care setting.Methods: This retrospective study included all patients admitted to the pediatric intensive care unit (PICU) of a tertiary hospital over a one-year period (March 2022–March 2023) who underwent nontunneled central venous catheter placement.Results: Among 174 patients included (median age 29 months, 60.3% male), 52.9% had SCV, 23.6% FV, and 23.6% IJV catheterization. The overall CVC success rate was 99.4%. There was no statistically significant difference in mechanical complications, catheter-related bloodstream infections, or thrombosis between groups, however, thrombosis occurred most frequently in the FV group (12.2%). The median age in the SCV group was significantly lower than in the other groups (20 months; interquartile range, 10–63; P<0.001), while the presence of chronic diseases was significantly higher in this group (P=0.02). In multivariate logistic regression, catheter site was identified as the only independent predictor of thrombosis, with FV catheterization associated with increased risk (OR, 2.75; P=0.016).Conclusions: SCV catheterization appears to be a feasible and safe option for critically ill children, even in younger patients and in the presence of chronic comorbidities. Despite potential technical challenges, SCV access represents a viable alternative to IJV and may offer potential advantages over FV, particularly with regard to thrombosis risk.
- 31 August 2026
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 41 (3) , 661-669
Open AccessSubclavian central venous catheterization in critically ill children in Türkiye: a safe and feasible approach in a single-center experience
Background: Central venous catheterization (CVC) is an essential procedure in the management of critically ill pediatric patients. However, the optimal catheter insertion site remains controversial due to varying complication rates. This study aimed to evaluate the feasibility and safety of subclavian vein (SCV) catheterization compared to femoral vein (FV) and internal jugular vein (IJV) access in a pediatric intensive care setting.Methods: This retrospective study included all patients admitted to the pediatric intensive care unit (PICU) of a tertiary hospital over a one-year period (March 2022–March 2023) who underwent nontunneled central venous catheter placement.Results: Among 174 patients included (median age 29 months, 60.3% male), 52.9% had SCV, 23.6% FV, and 23.6% IJV catheterization. The overall CVC success rate was 99.4%. There was no statistically significant difference in mechanical complications, catheter-related bloodstream infections, or thrombosis between groups, however, thrombosis occurred most frequently in the FV group (12.2%). The median age in the SCV group was significantly lower than in the other groups (20 months; interquartile range, 10–63; P<0.001), while the presence of chronic diseases was significantly higher in this group (P=0.02). In multivariate logistic regression, catheter site was identified as the only independent predictor of thrombosis, with FV catheterization associated with increased risk (OR, 2.75; P=0.016).Conclusions: SCV catheterization appears to be a feasible and safe option for critically ill children, even in younger patients and in the presence of chronic comorbidities. Despite potential technical challenges, SCV access represents a viable alternative to IJV and may offer potential advantages over FV, particularly with regard to thrombosis risk.
- Open Access
- 26 August 2026
- Published by Caleo in Turkish Archives of Pediatrics
Impact of Immunotherapy Combinations on Clinical Outcomes in Children with Acute Flaccid Paralysis: A Multicenter Intensive Care Study
Objective: Acute flaccid paralysis (AFP) is a syndrome characterized by the rapid onset of limb weakness and decreased muscle tone, frequently accompanied by respiratory or bulbar involvement. Methods: This retrospective multicenter study evaluated the clinical characteristics, treatment modalities, intensive care processes, and outcomes of 68 children diagnosed with AFP who were admitted to pediatric intensive care units (PICUs) between January 1, 2018, and January 1, 2023. Results: The patients’ ages ranged from 1 month to 18 years (mean 7.9 ± 4.5 years), and 33 (48.5%) were male. The mean PICU stay was 15.4 ± 19.5 days, and the mean total hospital stay was 23.3 ± 21.1 days. Respiratory support was required in 42 patients (61.8%). All patients received intravenous immunoglobulin (IVIG). Therapeutic plasma exchange (TPE) was administered to 25 of 43 Guillain–Barré syndrome (GBS) patients, 7 of 11 transverse myelitis (TM) patients, and 11 of 14 acute disseminated encephalomyelitis (ADEM) patients. Among 14 intubated GBS patients, 5 received IVIG for ≤2 days and 9 for ≥4 days. The duration of invasive mechanical ventilation (MV) was significantly longer in patients receiving IVIG for ≥4 days (P=.044). Guillain–Barré syndrome patients treated with combined IVIG and TPE had longer PICU stays compared with those receiving IVIG alone (P=.001). Conclusion: Combination immunotherapies were associated with longer MV duration and PICU stay compared with monotherapy in AFP patients. In intubated GBS patients, administration of IVIG over 2 days was associated with a shorter duration of invasive MV.
- 26 August 2026
- Published by Caleo in Turkish Archives of Pediatrics
Open AccessImpact of Immunotherapy Combinations on Clinical Outcomes in Children with Acute Flaccid Paralysis: A Multicenter Intensive Care Study
Objective: Acute flaccid paralysis (AFP) is a syndrome characterized by the rapid onset of limb weakness and decreased muscle tone, frequently accompanied by respiratory or bulbar involvement. Methods: This retrospective multicenter study evaluated the clinical characteristics, treatment modalities, intensive care processes, and outcomes of 68 children diagnosed with AFP who were admitted to pediatric intensive care units (PICUs) between January 1, 2018, and January 1, 2023. Results: The patients’ ages ranged from 1 month to 18 years (mean 7.9 ± 4.5 years), and 33 (48.5%) were male. The mean PICU stay was 15.4 ± 19.5 days, and the mean total hospital stay was 23.3 ± 21.1 days. Respiratory support was required in 42 patients (61.8%). All patients received intravenous immunoglobulin (IVIG). Therapeutic plasma exchange (TPE) was administered to 25 of 43 Guillain–Barré syndrome (GBS) patients, 7 of 11 transverse myelitis (TM) patients, and 11 of 14 acute disseminated encephalomyelitis (ADEM) patients. Among 14 intubated GBS patients, 5 received IVIG for ≤2 days and 9 for ≥4 days. The duration of invasive mechanical ventilation (MV) was significantly longer in patients receiving IVIG for ≥4 days (P=.044). Guillain–Barré syndrome patients treated with combined IVIG and TPE had longer PICU stays compared with those receiving IVIG alone (P=.001). Conclusion: Combination immunotherapies were associated with longer MV duration and PICU stay compared with monotherapy in AFP patients. In intubated GBS patients, administration of IVIG over 2 days was associated with a shorter duration of invasive MV.
- Open Access
- 16 June 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (3) , 708-717
Multiple organ dysfunction syndrome in pediatric colchicine poisoning: a national cohort study from Türkiye
Background/aim: Colchicine poisoning has been associated with systemic toxicity, multiple organ dysfunction syndrome (MODS), and mortality. In the present study, the demographic, clinical, and laboratory characteristics of pediatric colchicine poisoning cases and the incidence of organ failure are investigated to identify potential risk factors associated with MODS. Materials and methods: Included in this retrospective multicenter cohort study were pediatric patients admitted to 28 tertiary-care pediatric intensive care units with a diagnosis of colchicine poisoning. Demographic data, clinical and laboratory findings, and clinical outcomes were extracted from medical records. MODS was defined as dysfunction involving at least two organ systems. Multivariable logistic regression analysis was performed to identify the variables independently associated with MODS. Results: Of the 150 patients included in the study, 40% were younger than 5 years and 52% were older than 13 years. Gastrointestinal symptoms were most prominent, with nausea and vomiting observed in 64.7%, abdominal pain in 36.7%, and diarrhea in 24%. Overall, 66% developed no organ failure, while single-organ failure occurred in 7.3% and 26.7% developed MODS. The coagulation system was most frequently affected (26%), followed by the hematological (19.3%) and immunological (18%) systems. Multivariable logistic regression analysis identified the baseline PRISM III score, ingested colchicine dose per kilogram of body weight, and initial sodium, creatinine, and aspartate aminotransferase (AST) levels as independent predictors of MODS. Conclusion: MODS can develop at ingestion doses lower than 0.5 mg/kg, which have historically been considered safe. Higher ingested doses and elevated PRISM III scores were associated with MODS, although these findings are derived from retrospective observational data and should not be interpreted as causal or as direct clinical recommendations. Further prospective studies are needed to clarify relevant doses, interventions, and prognostic factors in pediatric colchicine poisoning associated with MODS.
- 16 June 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (3) , 708-717
Open AccessMultiple organ dysfunction syndrome in pediatric colchicine poisoning: a national cohort study from Türkiye
Background/aim: Colchicine poisoning has been associated with systemic toxicity, multiple organ dysfunction syndrome (MODS), and mortality. In the present study, the demographic, clinical, and laboratory characteristics of pediatric colchicine poisoning cases and the incidence of organ failure are investigated to identify potential risk factors associated with MODS. Materials and methods: Included in this retrospective multicenter cohort study were pediatric patients admitted to 28 tertiary-care pediatric intensive care units with a diagnosis of colchicine poisoning. Demographic data, clinical and laboratory findings, and clinical outcomes were extracted from medical records. MODS was defined as dysfunction involving at least two organ systems. Multivariable logistic regression analysis was performed to identify the variables independently associated with MODS. Results: Of the 150 patients included in the study, 40% were younger than 5 years and 52% were older than 13 years. Gastrointestinal symptoms were most prominent, with nausea and vomiting observed in 64.7%, abdominal pain in 36.7%, and diarrhea in 24%. Overall, 66% developed no organ failure, while single-organ failure occurred in 7.3% and 26.7% developed MODS. The coagulation system was most frequently affected (26%), followed by the hematological (19.3%) and immunological (18%) systems. Multivariable logistic regression analysis identified the baseline PRISM III score, ingested colchicine dose per kilogram of body weight, and initial sodium, creatinine, and aspartate aminotransferase (AST) levels as independent predictors of MODS. Conclusion: MODS can develop at ingestion doses lower than 0.5 mg/kg, which have historically been considered safe. Higher ingested doses and elevated PRISM III scores were associated with MODS, although these findings are derived from retrospective observational data and should not be interpreted as causal or as direct clinical recommendations. Further prospective studies are needed to clarify relevant doses, interventions, and prognostic factors in pediatric colchicine poisoning associated with MODS.
- Open Access
- 5 May 2025
- Published by Elsevier in World Neurosurgery: X
- Vol. 27
Early surgical intervention in pediatric trauma patients with GCS 3 – Results of 8 Years experience
- 5 May 2025
- Published by Elsevier in World Neurosurgery: X
- Vol. 27
Open AccessEarly surgical intervention in pediatric trauma patients with GCS 3 – Results of 8 Years experience
- 4 October 2023
- Published by Galenos Yayinevi in Turkish Journal of Pediatric Emergency and Intensive Care Medicine
- Vol. 10 (3) , 224-227
Moyamoya Disease, Which is Rare in Infancy: A Case Report
- 4 October 2023
- Published by Galenos Yayinevi in Turkish Journal of Pediatric Emergency and Intensive Care Medicine
- Vol. 10 (3) , 224-227
Moyamoya Disease, Which is Rare in Infancy: A Case Report
- Open Access
- 1 April 2023
- Published by Association of Pediatric Specialization Academy in Pediatric Academic Case Reports
- Vol. 2 (2) , 49-52
Neurological Complications in MIS-C: Case Report
COVID-19 has ser ously a ected ch ldren and the whole world. Ped atr c mult-system nflammatory syndrome (MIS-C), a new syndrome that has not been known before, has been descr bed. Although MIS-C may progress w th d erent cl n cal man festat ons n ch ldren, neurolog cal nvolvement s reported relat vely rarely. A 12-year-old g rl w th cerebral palsy and motor mental retardat on was adm tted to the emergency department w th compla nts of cough, fever, mouth sores and malnutr t on. As a result of the evaluat on, the pat ent was hosp tal zed to nvest gate the et ology of the fever and emp r cal ant b ot c treatment was started, and she developed a rash on the 3rd day and ton c-clon c convuls ons on the 5th day. The pat ent was hosp tal zed n the ped atr c ntens ve care un t (PICU), and COVID-19 IgG and IgM were pos t ve. Cerebral mag ng of the pat ent was reported as normal. The pat ent w th fever, rash, convuls ons last ng longer than f ve days, and compat ble laboratory results were d agnosed w th MIS-C. Intravenous mmunoglobul n (IVIG) and methylpredn solone treatments were started, and the pat ent was d scharged on the 14th day of hosp tal zat on, whose cond t on mproved. Th s case s presented as an example of the rare neurolog cal nvolvement of MIS-C. Deta led cl n cal nvest gat on and neurolog cal exam nat on are requ red to exclude neurolog cal sequelae of COVID-19 dur ng the pandem c. The development of general gu del nes that can comb ne them would be nstruct ve.
- 1 April 2023
- Published by Association of Pediatric Specialization Academy in Pediatric Academic Case Reports
- Vol. 2 (2) , 49-52
Open AccessNeurological Complications in MIS-C: Case Report
COVID-19 has ser ously a ected ch ldren and the whole world. Ped atr c mult-system nflammatory syndrome (MIS-C), a new syndrome that has not been known before, has been descr bed. Although MIS-C may progress w th d erent cl n cal man festat ons n ch ldren, neurolog cal nvolvement s reported relat vely rarely. A 12-year-old g rl w th cerebral palsy and motor mental retardat on was adm tted to the emergency department w th compla nts of cough, fever, mouth sores and malnutr t on. As a result of the evaluat on, the pat ent was hosp tal zed to nvest gate the et ology of the fever and emp r cal ant b ot c treatment was started, and she developed a rash on the 3rd day and ton c-clon c convuls ons on the 5th day. The pat ent was hosp tal zed n the ped atr c ntens ve care un t (PICU), and COVID-19 IgG and IgM were pos t ve. Cerebral mag ng of the pat ent was reported as normal. The pat ent w th fever, rash, convuls ons last ng longer than f ve days, and compat ble laboratory results were d agnosed w th MIS-C. Intravenous mmunoglobul n (IVIG) and methylpredn solone treatments were started, and the pat ent was d scharged on the 14th day of hosp tal zat on, whose cond t on mproved. Th s case s presented as an example of the rare neurolog cal nvolvement of MIS-C. Deta led cl n cal nvest gat on and neurolog cal exam nat on are requ red to exclude neurolog cal sequelae of COVID-19 dur ng the pandem c. The development of general gu del nes that can comb ne them would be nstruct ve.
- 30 March 2023
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 17 (1) , 28-35
Pseudo-Outbreaks of Stenotrophomonas maltophilia on a Pediatric Intensive Care Unit in Türkiye
- 30 March 2023
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 17 (1) , 28-35
Pseudo-Outbreaks of Stenotrophomonas maltophilia on a Pediatric Intensive Care Unit in Türkiye
- 30 March 2023
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 17 (1) , 27-34
Pseudo-Outbreaks of Stenotrophomonas maltophilia on a Pediatric Intensive Care Unit in Türkiye
- 30 March 2023
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 17 (1) , 27-34
Pseudo-Outbreaks of Stenotrophomonas maltophilia on a Pediatric Intensive Care Unit in Türkiye
- 15 March 2023
- Published by Georg Thieme Verlag KG in Journal of Pediatric Intensive Care
Descriptive and Clinical Characteristics of Nonsurvivors in a Tertiary Pediatric Intensive Care Unit in Turkey: 6 Years of Experience
The objective of this study was to identify the characteristics of nonsurvivors in a pediatric intensive care unit (PICU) in Turkey. This is a retrospective analysis of patients who died in a tertiary PICU over a 6-year period from 2016 to 2021. Data were drawn from electronic medical records and resuscitation notes. Mode of death was categorized as failed cardiopulmonary resuscitation (F-CPR) or brain death. Among the 161 deaths, 136 nonsurvivors were included and 30.1% were younger than 1 year. Severe pneumonia, respiratory failure, and acute respiratory distress syndrome (ARDS) (31.6%) were the most common primary diagnoses. The most common mode of death was F-CPR (86.8%). More than half of the subjects had been admitted from pediatric emergency departments (58.1%), and more than half (53.7%) had died within 7 days in the PICU. Patients admitted from pediatric emergency departments had the lowest frequency of comorbidities (p < 0.001). Severe pneumonia, respiratory failure, and ARDS diagnoses were significantly more frequent in those who died after 7 days (p < 0.001), whereas septicemia, shock, and multiple organ dysfunction were more common among those who died within the first day of PICU admission (p < 0.001). It may be important to note that patients referred from wards are highly likely to have comorbidities, while those referred from pediatric emergency departments may be relatively younger. Additionally, patients with septicemia, shock, or multiple organ dysfunction were more likely to die earlier (within 7 days), especially compared with those with severe pneumonia, respiratory failure, or ARDS.
- 15 March 2023
- Published by Georg Thieme Verlag KG in Journal of Pediatric Intensive Care
Descriptive and Clinical Characteristics of Nonsurvivors in a Tertiary Pediatric Intensive Care Unit in Turkey: 6 Years of Experience
The objective of this study was to identify the characteristics of nonsurvivors in a pediatric intensive care unit (PICU) in Turkey. This is a retrospective analysis of patients who died in a tertiary PICU over a 6-year period from 2016 to 2021. Data were drawn from electronic medical records and resuscitation notes. Mode of death was categorized as failed cardiopulmonary resuscitation (F-CPR) or brain death. Among the 161 deaths, 136 nonsurvivors were included and 30.1% were younger than 1 year. Severe pneumonia, respiratory failure, and acute respiratory distress syndrome (ARDS) (31.6%) were the most common primary diagnoses. The most common mode of death was F-CPR (86.8%). More than half of the subjects had been admitted from pediatric emergency departments (58.1%), and more than half (53.7%) had died within 7 days in the PICU. Patients admitted from pediatric emergency departments had the lowest frequency of comorbidities (p < 0.001). Severe pneumonia, respiratory failure, and ARDS diagnoses were significantly more frequent in those who died after 7 days (p < 0.001), whereas septicemia, shock, and multiple organ dysfunction were more common among those who died within the first day of PICU admission (p < 0.001). It may be important to note that patients referred from wards are highly likely to have comorbidities, while those referred from pediatric emergency departments may be relatively younger. Additionally, patients with septicemia, shock, or multiple organ dysfunction were more likely to die earlier (within 7 days), especially compared with those with severe pneumonia, respiratory failure, or ARDS.